AURA
Aura Biosciences Inc.
$6.19
+$0.02(+0.41%)
66
Overall
--
Value
66
Tech
--
Quality
Market Cap
$390.73M
Volume
121.03K
52W Range
$4.35 - $12.38
Target Price
$21.50
Order:
Income Statement
| Metric | Trend | Chart | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|
| OPERATING EXPENSES | ||||||
| Operating Expenses | $35.3M | $60.3M | $85.0M | $96.1M | ||
| Research & Development | $25.2M | $42.2M | $65.2M | $73.3M | ||
| Research Expense | $25.2M | $42.2M | $65.2M | $73.3M | ||
| Selling, General & Administrative | $10.1M | $18.1M | $19.8M | $22.8M | ||
| General & Administrative Expenses | $10.1M | $18.1M | $19.8M | $22.8M | ||
| Salaries & Wages | -- | -- | $8.8M | $11.7M | ||
| Depreciation & Amortization | $800.0K | $1.2M | $1.3M | $1.2M | ||
| Depreciation & Amortization | $800.0K | $1.2M | $1.3M | $1.2M | ||
| Amortization | $11.0K | -- | -- | -- | ||
| Other Operating Expenses | $861.0K | $3.1M | $4.4M | -- | ||
| OPERATING INCOME | ||||||
| Operating income | $-35.3M | $-60.3M | $-85.0M | $-96.1M | ||
| EBITDA | $-34.4M | $-59.1M | $-75.0M | $-85.6M | ||
| NON-OPERATING ITEMS | ||||||
| Intinc | $13.0K | $1.9M | $8.6M | $9.4M | ||
| Net Non-Operating Interest Income/Expense | $13.0K | $1.9M | $8.6M | $9.4M | ||
| Gain on Sale of Securities | -- | $-9.0K | -- | -- | ||
| Other Income/Expense | $3.0K | $-332.0K | $-132.0K | $120.0K | ||
| Other Special Charges | $-11.0K | $-14.0K | $-76.0K | $-120.0K | ||
| PRE-TAX INCOME | ||||||
| EBIT | $-35.2M | $-60.3M | $-76.3M | $-86.8M | ||
| Pre-Tax Income | $-35.2M | $-58.8M | $-76.3M | $-86.8M | ||
| INCOME TAX | ||||||
| Tax Provision | -- | -- | $137.0K | $112.0K | ||
| NET INCOME | ||||||
| Net Income | $-35.3M | $-58.8M | $-76.4M | $-86.9M | ||
| Net Income (Continuing Operations) | $-35.3M | $-58.8M | $-76.4M | $-86.9M | ||
| Net Income (Discontinued Operations) | $-35.3M | $-58.8M | $-76.4M | $-86.9M | ||
| Net Income (Common Stockholders) | $-35.2M | $-58.8M | $-76.4M | $-86.9M | ||
| Normalized Income | -- | -- | -- | $-85.9M | ||
| TOTALS | ||||||
| Total Expenses | $35.3M | $60.3M | $85.0M | $96.1M | ||
| SHARE & EPS DATA | ||||||
| Average Shares Outstanding | $5.2M | $29.9M | $39.6M | $49.7M | ||
| Average Shares Outstanding (Diluted) | -- | $29.9M | $39.6M | $49.7M | ||
| Shares Outstanding | $62.1M | $37.8M | $49.5M | $50.2M | ||
| Basic EPS | $-8.95 | $-1.96 | $-1.93 | $-1.75 | ||
| Basic EPS (Continuing Operations) | $-8.95 | $-1.96 | $-1.93 | $-1.75 | ||
| Diluted EPS | $-8.95 | $-1.96 | $-1.93 | $-1.75 | ||
| Diluted EPS (Continuing Operations) | -- | $-1.96 | $-1.93 | $-1.75 | ||
| OTHER METRICS | ||||||
| Accretion On Preferred Stock | $10.9M | -- | -- | -- | ||
| Accrued Preferred Stock Dividends | $10.9M | -- | -- | -- | ||
| Gain On Sale Of P P E | $-3.0K | $-318.0K | $208.0K | -- | ||
| Other Gand A | $10.1M | $18.1M | $19.8M | $22.8M | ||
| Otherunder Preferred Stock Dividend | $10.9M | -- | -- | -- | ||
| Preferred Stock Dividends | $10.9M | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AURA | $6.19 | +0.4% | 121.03K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |